Testing effectiveness (Phase 2)Ended earlyNCT00810017
What this trial is testing
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Who this might be right for
HER-2 Positive Metastatic Breast Cancer
Medstar Health Research Institute 2